PCG Wealth Advisors’s Praxis Precision Medicines PRAX Stock Holding History

PCG Wealth Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,483	Closed	-$768K	–	157
2025 Q3	$768K	Buy	+14,483	New	+$702K	0.22%	90
2025 Q2	–	Sell	-16,413	Closed	-$622K	–	124
2025 Q1	$622K	Sell	16,413 -869	-5%	-$54.3K	0.22%	81
2024 Q4	$1.33M	Sell	17,282 -77	-0.4%	-$5.57K	0.49%	62
2024 Q3	$999K	Sell	17,359 -82	-0.5%	-$4.43K	0.39%	63
2024 Q2	$721K	Buy	17,441 +4,524	+35%	+$214K	0.31%	65
2024 Q1	$788K	Buy	+12,917	New	+$579K	0.37%	56
2023 Q4	–	Sell	-1,967	Closed	-$50.4K	–	112
2023 Q3	$50.4K	Buy	+1,967	New	+$37.2K	0.03%	102

Other funds holding PRAX

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

PCG Wealth Advisors's PRAX Position: Q4 2025 in Review

PCG Wealth Advisors sold out of Praxis Precision Medicines (PRAX) in Q4 2025, closing a stake of 14,483 shares — an estimated $768K sold.

PCG Wealth Advisors first reported a position in PRAX in Q3 2023 and held it in 7 quarters. The position peaked at $1.33M in Q4 2024. 250 funds tracked by Wall St. Rank hold PRAX as of Q4 2025.

PCG Wealth Advisors reported no remaining Praxis Precision Medicines position as of Q4 2025 after selling out during the quarter.
PCG Wealth Advisors sold 14,483 Praxis Precision Medicines shares in Q4 2025, an estimated $768K.
PCG Wealth Advisors first reported a position in Praxis Precision Medicines in Q3 2023 and held it in 7 quarters.
PCG Wealth Advisors's Praxis Precision Medicines position peaked at $1.33M in Q4 2024.
250 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q4 2025.

Based on PCG Wealth Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.